Recent Company News

• 06:27 PM ET Jan 05, 2026
  

  SanBio upgraded to neutral from sell at Citi (¥1637.0000, 0)

• 01:01 AM ET Dec 16, 2025
  

  Street Takeaways - SanBio 9M/Q3 earnings (¥1620.0000, -45)

• 01:35 AM ET Dec 15, 2025
  

  SanBio reports 9M net income attributable (¥2.71B) vs year-ago (¥2.15B) (¥1665.0000, 0)

• 03:37 PM ET Dec 14, 2025
  

  UBS initiates 4521.JP, 4527.JP, 4547.JP, and 4592.JP

• 01:40 AM ET Dec 09, 2025
  

  SanBio obtains Japan MHLW's partial change approval for AKUUGO suspension for intracranial implantation (¥1733.0000, 0)

• 09:35 AM ET Nov 06, 2025
  

  SanBio's 6.0M-share international offering priced at ¥2,487/share, raising ¥14.92B (¥2734.0000, 0)

• 02:04 AM ET Nov 06, 2025
  

  SanBio to issue 6.0M shares through international offering; pricing to take place today or tomorrow (¥2734.0000, 0)